Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...
Catherine Oldenburg: The ACTION trial is a nationwide trial in the United States that is designed to evaluate the efficacy of a single dose of azithromycin compared to placebo for [the] prevention of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback